# US 2012/0251447 A1 · Radioiodinated tropane derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251447 A1
- Document ID: US20120251447A1
- Status: Published application
- Kind: A1
- Application number: 13/513,650
- Filed: 2010-12-21
- Published: 2012-10-04
- Earliest claimed: 2009-12-22
- Inventors: Michelle Emma Avory; Harry John Wadsworth; Robert James Domett Nairne
- Web page: https://patentgrep.com/patent/US20120251447A1

## CPC

- C07D 451/02: containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- A61K 51/0448: {tropane or nortropane groups, e.g. cocaine}
- A61K 51/0455: {having six-membered rings with one nitrogen as the only ring hetero atom}
- A61P 25/00: Drugs for disorders of the nervous system
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides novel radio iodinated tropanes incorporating triazole or isoxazole rings. Also provided are methods of preparation of said tropanes from functionalised tropane precursors, using click cycloaddition chemistry, as well as radiopharmaceutical compositions comprising such radio iodinated tropanes. The invention also provides in vivo imaging methods using the radio iodinated tropanes.

## Claims

### Claim 1

A radioiodinated tropane of Formula (I):
where:
R1 is C1-4 alkyl, C1-4 fluoroalkyl or Y;
R2 is —CO2R or Y, wherein R is C1-4 alkyl, C5-8 aryl or C5-10 aralkyl;
R3 is Y or R4, where R4 is of formula:
where R5 is Hal, CH3 or Y;
Y is a Y1 or Y2 group:
L1 is a linker group which may be present or absent;
I* is a radioisotope of iodine;
wherein R1 to R5 are chosen such that the tropane of Formula (I) comprises one Y group.

### Claim 2 (depends on 1)

The radioiodinated tropane of claim 1, wherein I* is chosen from 123I, 124I or 131I.

### Claim 3 (depends on 1)

The radioiodinated tropane of claim 1, where Y is Y1.

### Claim 4 (depends on 1)

The radioiodinated tropane of claim 1, where R1 is Y, R2 is —CO2R and R3 is R4 wherein R5 is Hal or CH3.

### Claim 5 (depends on 1)

The radioiodinated tropane of claim 1, where R2 is Y, R1 is C1-4 fluoroalkyl, and R3 is R4 wherein R5 is Hal or CH3.

### Claim 6 (depends on 1)

A method of preparation of the radioiodinated tropane of Formula (I) as defined in claim 1, where said method comprises:
(i) provision of a precursor of Formula (IA)
where:
R1a is C1-4 alkyl, C1-4 fluoroalkyl or Ya;
R2a is —CO2R or Ya, wherein R is C1-4 alkyl, C5-8 aryl or C5-10 aralkyl;
R3a is Ya or R4a, where R4a is of formula:
where R5a is Hal, CH3 or Ya;
Ya is a Y1a or Y2a group:
L1 is a linker group which may be present or absent;
wherein R1a to R5a are chosen such that the precursor of Formula (IA) comprises one Ya group;
(ii) reaction of said precursor with a compound of Formula (II):
in the presence of a click cycloaddition catalyst, to give the radioiodinated tropane of Formula (I) via click cycloaddition,
wherein I* is a radioisotope of iodine, as defined in claim 1.

### Claim 7 (depends on 6)

The method of claim 6, where the click cycloaddition catalyst comprises Cu(I).

### Claim 8 (depends on 6)

The method of claim 6, where the compound of Formula (II) is generated in situ by deprotection of a compound of Formula (IIa):
wherein M1 is an alkyne-protecting group.

### Claim 9 (depends on 1)

A method of preparation of the radioiodinated tropane of Formula (I) as defined in claim 1, where said method comprises:
(i) provision of a precursor of Formula (IB):
where:
R1 is C1-4 alkyl, C1-4 fluoroalkyl or Yb;
R2 is —CO2R or Yb, wherein R is C1-4 alkyl, C5-8 aryl or C5-10 aralkyl;
R3 is Yb or R4, where R4 is of formula:
where R5 is Hal, CH3 or Yb;
Yb is a Y1b or Y2b group:
L1 is a linker group which may be present or absent;
wherein Q is Ra3Sn— or KF3B—, where each Ra is independently C1-4 alkyl; and wherein R1 to R5 are chosen such that the precursor of Formula (IB) comprises one Yb group;
(ii) reaction of said precursor with radioactive iodide ion in the presence of an oxidising agent to give the radioiodinated tropane of Formula (I).

### Claim 10 (depends on 6)

The method of claim 6, which is carried out in an aseptic manner, such that the product of Formula (I) is obtained as a radiopharmaceutical composition.

### Claim 11 (depends on 6)

The method of claim 6, which is carried out using an automated synthesizer apparatus.

### Claim 12 (depends on 1)

A radiopharmaceutical composition comprising an effective amount of the radioiodinated tropane of Formula (I) as defined in claim 1, together with a biocompatible carrier medium.

### Claim at position 13

13-14. (canceled)

### Claim 15 (depends on 12)

A method of generating an image of a human or animal body comprising administering the radioiodinated tropane of Formula (I) as defined in the radiopharmaceutical composition of claim 12, and generating an image of at least a part of said body to which said compound or composition has distributed using PET or SPECT.

### Claim 16 (depends on 12)

A method of monitoring the effect of treatment of a human or animal body with a drug, said method comprising administering to said body the radioiodinated tropane of Formula (I) as defined in the radiopharmaceutical composition of claim 12, and detecting the uptake of said tropane or composition in at least a part of said body to which said tropane or composition has distributed using PET or SPECT, said administration and detection optionally but preferably being effected before, during and after treatment with said drug.
